Earnings Call · Q1 FY2022·2022-05-04

Q1 22EPS +4.00%·Rev n/aQ4 21EPS -89.31%·Rev n/aQ3 21EPS +2.10%·Rev n/aQ2 21EPS +30.77%·Rev n/a⚠ consensus missing

Evofem Biosciences, Inc. EVFM

Amy Raskopf — Investor Relations

Saundra Pelletier — Chief Executive Officer

Jay File — Chief Financial Officer

−33.3%1d on move date−29.8% vs SPY3d−51.1%5d−56.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EVFM calls or request research access.

More EVFM calls Browse calls Request research access